The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib (cabo) combined with durvalumab (durva) in gastroesophageal (GE) cancer and other gastrointestinal (GI) malignancies: Preliminary phase Ib CAMILLA study results.
 
Anwaar Saeed
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Merck Sharp & Dohme (Inst); Seagen (Inst)
 
Milind Phadnis
No Relationships to Disclose
 
Robin Park
No Relationships to Disclose
 
Weijing Sun
Honoraria - Genentech/Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer
Research Funding - Bayer; Merck (Inst)
 
Raed Moh'd Taiseer Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Sirtex Medical
Research Funding - EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Joaquina Celebre Baranda
Stock and Other Ownership Interests - Adaptimmune; Forty Seven; Hylapharm; Ignyta; Loxo; Zymeworks (I)
Research Funding - Astellas Pharma; Exelixis; Incyte; Lilly; Pfizer; Regeneron; Tolero Pharmaceuticals; Xencor
Travel, Accommodations, Expenses - Sanofi
 
Stephen K. Williamson
Research Funding - Acceleron Pharma (Inst); Aleon Pharma (Inst); Astellas Pharma (Inst); Bayer Health (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Merck Serono (Inst); Nektar (Inst); Novartis (Inst); Pharmacyclics (Inst); Regeneron (Inst); Rogosin Institute (Inst); Sanofi (Inst); Seagen (Inst); Sotio (Inst)
 
Zachary Collins
No Relationships to Disclose
 
Jeanette Firth-Braun
No Relationships to Disclose
 
Azhar Saeed
No Relationships to Disclose
 
Carolyn Foster
No Relationships to Disclose
 
Benjamin Roberts
No Relationships to Disclose
 
Dharmalingam Subramaniam
No Relationships to Disclose
 
Anup Kasi
Honoraria - OncLive
Research Funding - Astellas Pharma (Inst); Geistlich Pharma (Inst); Halozyme (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
Travel, Accommodations, Expenses - Halozyme; Rafael Pharmaceuticals
 
Shrikant Anant
No Relationships to Disclose